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Cardiac output is a primary determinant of global oxygen
transport from the heart to the body. Also, because the major
function of the cardiovascular system is to supply sufficient
amounts of oxygen to meet the metabolic demands of the
tissues, it appears reasonable to measure cardiac output in the
assessment of cardiovascular insufficiency. Regrettably,
numerous studies have shown that neither absolute values for
cardiac output nor its change in response to therapy reflect the
adequacy of local blood flow or outcome from critical illness
[1,2]. Clearly, one may have a cardiac output within the normal
range (e.g. 2.5l/min perm2) and still be in circulatory shock if
metabolic demand is increased or blood flow distribution is
deranged. Treating septic shock patients with the goal of
augmenting cardiac output to high levels (i.e. >3.5l/min
perm2) does not improve survival rates [3–5] and may actually
increase mortality [6]. Thus, why measure cardiac output?
Clearly, a very low cardiac output is detrimental. Critically ill
patients who are unable to sustain a cardiac index in excess
of 2l/min perm2, despite aggressive therapy, have a very
high mortality rate [4]. In many of these patients the cause of
the low cardiac output is inadequate cardiac filling, which is
responsive to fluid resuscitation. However, in patients with
combined cardiac and respiratory disease, it is often difficult
to assess the adequacy of resuscitation without
measurement of cardiac output. Furthermore, a recent single
center study of septic patients treated in an emergency
department [7] documented that rapid early resuscitation
with a goal of re-establishing adequate oxygen delivery
resulted in a markedly reduced mortality and duration of
hospital stay. Thus, at least in some patients, measurement of
cardiac output is indicated as an aid to prognosis and
diagnosis, and to monitor the adequacy of therapy.
If it is useful to measure cardiac output, then it is also
important that its measurement be accurate enough to
identify clinically relevant changes. There is no agreement as
to what constitutes a clinically relevant change in cardiac
output. Operationally, changes in cardiac output of 15% or
more are usually taken to reflect a relevant change, because
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Abstract
Although cardiac output is a primary determinant of global O2 transport there are no absolute values
that reflect circulatory adequacy, though very low values are of negative prognostic use. There is no
agreement as to what constitutes a clinically relevant change in cardiac output. A recent clinical trial
suggests that early goal-directed therapy aimed at increasing cardiac output improves survival. Thus, in
some patients, measurement of cardiac output is indicated as an aid to prognosis, diagnosis and to
monitor the adequacy of therapy. Gonzalez et al. compared PAC thermodilution cardiac output with
indirect Fick measures of cardiac output. They found that at lower cardiac outputs (<5 l/min) the
agreement between the two techniques is good, whereas at higher flows increased differences exist
between the two measures. As discussed in this commentary, this study did not address the three
potential questions related to PAC monitoring of cardiac output. These questions are: can the PAC
cardiac output data be used to monitor cardiac output? Do technical and physiological constraints limit
the accuracy of PAC cardiac output? And; are PAC cardiac output measurement errors due to
respiratory variation in pulmonary blood flow? Ways of answering each question are given.
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such changes are at the limit of accuracy of present day
measuring techniques and are above the degree of normal
variance seen in an otherwise stable person. Furthermore,
measurements of cardiac output need to be taken repetitively
if they are to be useful in the management of the
hemodynamically unstable patient. At the present time the
clinician has available an increasing number of potential
measuring devices that all purport to measure cardiac output.
These include indicator dilution techniques, with or without
the use of a pulmonary artery catheter (PAC); arterial pulse
contour techniques; aortic pulsed Doppler, both of the
ascending and descending aortas; and classical indirect
measures of cardiac output using arteriovenous gas content
differences and expired gas measures via the Fick equation.
Each technique has its own strengths and limitations.
Realistically, bolus thermodilution measures of pulmonary
blood flow using a balloon floatation PAC is the most
common technique available and is the method most often
used to measure cardiac output in clinical reports.
Numerous studies over the years have compared PAC
thermodilution cardiac output with indirect Fick and aortic
flow probe derived measures of cardiac output. In general,
they all arrive at the same conclusions. First, because the
PAC thermodilution technique measures pulmonary blood
flow over a very short time window of 1.5–3s, the measured
cardiac output values are influenced by the phase of the
respiratory cycle during which the injection occurs [8].
Second, the manual cold bolus injection technique is subject
to systematic bias and intraoperator variability because of
errors in ejection technique, and these are independent of
the actual accuracy of individual measures of blood flow.
Thus, numerous mechanical injection techniques and timed
manual injection techniques have been proposed to minimize
this problem [9]. Given the above physiologic and technical
limitations, it is usually assumed that measures of cardiac
output within 15–20% of previous measures reflect no real
change in measured flow, but is this assumption correct?
In this issue of Critical Care, Gonzalez and coworkers [10]
readdress this question. That prospective observational
study, conducted in 18 mechanically ventilated critically ill
patients, compared agreement in 49 paired measures of
cardiac output using the modified Stewart–Hamilton
equation and bolus thermodilution from a PAC with the
indirect Fick technique using oxygen uptake at the mouth and
arteriovenous oxygen content differences. Those
investigators reported that at lower cardiac outputs (<5l/min
perm2) the agreement between the two techniques is good,
whereas at higher flows increased differences exist between
the two measures. They concluded that the thermodilution
technique is still clinically valuable in assessing cardiac
output. Interestingly, their finding of increased differences in
paired values at higher cardiac outputs illustrates a
systematic bias between the two techniques, rather than a
cutoff value below which the two techniques agree.
Regrettably, the study design does not allow sufficient data
to make their stated conclusion in a clinically relevant
manner. Protocol design becomes a central feature of this
type of experiment and can be used to illustrate how such
paired cardiac output data can be collected and used to
make valuable inferences.
If the question were ‘Can the cardiac output data from the
PAC be used to monitor cardiac output?’, then one would
need to know not only whether the two measures agree at
one point in time but also whether they also track each other
as cardiac output varies over time. There are two qualities of
a hemodynamic measure that are clinically relevant: first, if no
change in cardiac output measure occurs, then the absolute
value for cardiac output is accurate and has not changed
between the measuring intervals; and second, if a change in
cardiac output occurs, then the direction and magnitude are
accurately reflected in the measured cardiac output change.
Thus, a minimum of two sets of paired observations
separated by an intervention presumed to alter cardiac
output would need to be performed to address this issue.
If the question were ‘Do technical and physiologic
constraints limit the accuracy of PAC thermodilution
measures of cardiac output?’, then different injection
techniques, injectate temperatures, and respiratory rates
would need to be studied, and inclusion of patients with
varying degrees of hemodynamic stability would be required.
Because any inaccuracy present in the measure of cardiac
output by thermodilution reflects not only technical aspects
of consistency of injection, catheter temperature, and sensor
responsiveness, but also physiologic variables such as
ventilation-induced variations in both pulmonary arterial blood
flow and tricuspid regurgitation.
If the question were ‘Are measurement errors due to
respiratory variation in pulmonary blood flow not seen when
measures are made over many respiratory cycles?’, then
differences between thermodilution and metabolic estimates
of cardiac output could be compared, with great attention
paid to partitioning the injections throughout the cardiac
cycle rather than timing all injections with a specific point in
the ventilatory cycle. Picking a specific point in the respiratory
cycle does not allow for a more consistent determination of
cardiac output but decreases the accuracy of the absolute
value; this is because true blood flow varies over the
ventilatory cycle. The advantage of comparing the
thermodilution technique with an indirect Fick technique is
that the indirect Fick technique measures the average
cardiac output over several minutes. Thus, differences
between measures will better reflect either direct
measurement error or measurement of different actual
variations. The indirect Fick method also carries significant
bias if lung oxygen consumption is large because the
arteriovenous oxygen difference calculation assumes
negligible lung oxygen consumption. Thus, if lung oxygen116
Critical Care    April 2003 Vol 7 No 2 Pinsky
consumption were increased, as is the case with acute lung
injury and acute pneumonitis, then the Fick technique would
overestimate true cardiac output.
In the final analysis PAC bolus thermodilution measures of
cardiac output, if performed correctly and with inspection of
the thermal decay profile to identify poor injection runs, give
cardiac output values that may vary by up to 25% at low
cardiac outputs (<2l/min perm2) and 20% at higher cardiac
outputs, without reliably reflecting actual changes in cardiac
output. Although newer and more precise thermodilution
techniques exist, they are not readily available. Thus, the use
of cardiac output measures as single variables in defining
disease and response to therapy require very large
differences to reflect actual changes and, outside of
simultaneous oxygen consumption measures, often give little
insight into the mechanisms responsible for hemodynamic
instability and circulatory shock or their response to therapy.
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